Abiopharma

🔍 WALL JOHN M (Executive)

Company: CADENCE DESIGN SYSTEMS INC (CDNS)

Report Date: 2026-03-18

Detailed Transactions and Holdings:

• Acquired 43,239 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 104,198.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 8,416 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 112,614.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 4,239 shares of Common Stock at $289.64 per share (Direct)
  Date: 2026-03-18 | Code: F | equity_swap_involved: 0 | shares_owned_after: 108,375.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Represents Performance-Based Restricted Stock Units that have met the performance criteria.
• F2: Represents Performance-Based Restricted Stock Units that have met the performance criteria, which vest in three equal annual installments on the first, second and third anniversaries of the grant date subject to continued service.
• F3: Shares withheld to satisfy tax obligations arising out of vesting of Performance-Based Restricted Stock Units that have met the performance criteria.